Consainsights logo

Poultry Diagnostics Market

Poultry Diagnostics Market Market Research Report – Segmented By Test Type (Enzyme-Linked Immunosorbent Assay (Elisa) Tests, Polymerase Chain Reaction (PCR) Tests, Other Diagnostic Tests), By Disease Type (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, Infectious Bursal Disease, Avian Pasteurellosis, Avian Encephalomyelitis, Avian Reovirus, Chicken Anemia), By Services (Virology, Bacteriology, Parasitology), By Region (North America, Europe, Asia-Pacific, Rest of the World) & Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.

Table of contents

Executive Summary

Poultry Diagnostics Market was valued at US $495.50 million in 2021 and is projected to grow at 10.55% CAGR over the forecast period to reach US $904.59 million by 2027. Poultry Diagnostics Market represented US $90.08 million opportunity over 2019-2021 and estimated to create US $409.09 million opportunity in 2027 over 2021.

Poultry Diagnostics Market Size (2019 - 2027), USD million

Poultry Diagnostics from Consainsights analyses the Poultry Diagnostics Market in the Life Sciences industry over the forecast period to 2027.

Poultry Diagnostics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Poultry Diagnostics segmentation includes Test Type, Disease Type, Services, Region and Geography.

Based on the Test Type, the Poultry Diagnostics analysis covers Enzyme-Linked Immunosorbent Assay (Elisa) Tests, Polymerase Chain Reaction (PCR) Tests, Other Diagnostic Tests.

In Test Type segment, Enzyme-Linked Immunosorbent Assay (Elisa) Tests segment has highest cagr growth of 9.33%.

Revenue Share (%), By Test Type (2021)

Based on the Disease Type, the Poultry Diagnostics analysis covers Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, Infectious Bursal Disease, Avian Pasteurellosis, Avian Encephalomyelitis, Avian Reovirus, Chicken Anemia.

In Disease Type segment, Avian Salmonellosis segment has highest cagr growth of 9.33%.

Revenue Share (%), By Disease Type (2021)

Based on the Services, the Poultry Diagnostics analysis covers Virology, Bacteriology, Parasitology.

In Services segment, Virology segment has highest cagr growth of 9.33%.

Revenue Share (%), By Services (2021)

Based on the Region, the Poultry Diagnostics analysis covers North America, Europe, Asia-Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 9.33%.

Revenue Share (%), By Region (2021)

Based on the region, the Poultry Diagnostics analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Test Type

Introduction

In 2021, Enzyme-Linked Immunosorbent Assay (Elisa) Tests segment has the highest revenue of US $222.74 million and is expected to grow at CAGR of 9.33% by 2027 Enzyme-Linked Immunosorbent Assay (Elisa) Tests segment has highest cagr growth of 9.33%.

Poultry Diagnostics Market Y-o-Y Growth (USD million), By Test Type 2019 - 2027
Poultry Diagnostics Market Size, By Test Type, 2019-2027 (USD million)

Enzyme-Linked Immunosorbent Assay (Elisa) Tests

Enzyme-Linked Immunosorbent Assay (Elisa) Tests segment was valued at US $182.25 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $406.65 million by 2027. Enzyme-Linked Immunosorbent Assay (Elisa) Tests segment represented US $40.49 million opportunity over 2019-2021 and estimated to create US $183.90 million opportunity in 2027 over 2021.

Enzyme-Linked Immunosorbent Assay (Elisa) Tests - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Polymerase Chain Reaction (PCR) Tests

Polymerase Chain Reaction (PCR) Tests segment was valued at US $130.67 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $291.56 million by 2027. Polymerase Chain Reaction (PCR) Tests segment represented US $29.03 million opportunity over 2019-2021 and estimated to create US $131.85 million opportunity in 2027 over 2021.

Polymerase Chain Reaction (PCR) Tests - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Other Diagnostic Tests

Other Diagnostic Tests segment was valued at US $92.50 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $206.38 million by 2027. Other Diagnostic Tests segment represented US $20.55 million opportunity over 2019-2021 and estimated to create US $93.34 million opportunity in 2027 over 2021.

Other Diagnostic Tests - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Disease Type

Introduction

In 2021, Avian Salmonellosis segment has the highest revenue of US $189.12 million and is expected to grow at CAGR of 9.33% by 2027 Avian Salmonellosis segment has highest cagr growth of 9.33%.

Poultry Diagnostics Market Y-o-Y Growth (USD million), By Disease Type 2019 - 2027
Poultry Diagnostics Market Size, By Disease Type, 2019-2027 (USD million)

Avian Salmonellosis

Avian Salmonellosis segment was valued at US $154.74 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $345.27 million by 2027. Avian Salmonellosis segment represented US $34.38 million opportunity over 2019-2021 and estimated to create US $156.15 million opportunity in 2027 over 2021.

Avian Salmonellosis - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Avian Influenza

Avian Influenza segment was valued at US $93.81 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $209.31 million by 2027. Avian Influenza segment represented US $20.84 million opportunity over 2019-2021 and estimated to create US $94.66 million opportunity in 2027 over 2021.

Avian Influenza - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Newcastle Disease

Newcastle Disease segment was valued at US $59.23 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $132.16 million by 2027. Newcastle Disease segment represented US $13.16 million opportunity over 2019-2021 and estimated to create US $59.77 million opportunity in 2027 over 2021.

Newcastle Disease - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Avian Mycoplasmosis

Avian Mycoplasmosis segment was valued at US $35.07 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $78.26 million by 2027. Avian Mycoplasmosis segment represented US $7.79 million opportunity over 2019-2021 and estimated to create US $35.39 million opportunity in 2027 over 2021.

Avian Mycoplasmosis - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Infectious Bronchitis

Infectious Bronchitis segment was valued at US $23.53 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $52.51 million by 2027. Infectious Bronchitis segment represented US $5.23 million opportunity over 2019-2021 and estimated to create US $23.75 million opportunity in 2027 over 2021.

Infectious Bronchitis - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Infectious Bursal Disease

Infectious Bursal Disease segment was valued at US $15.18 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $33.86 million by 2027. Infectious Bursal Disease segment represented US $3.37 million opportunity over 2019-2021 and estimated to create US $15.31 million opportunity in 2027 over 2021.

Infectious Bursal Disease - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Avian Pasteurellosis

Avian Pasteurellosis segment was valued at US $10.33 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $23.04 million by 2027. Avian Pasteurellosis segment represented US $2.29 million opportunity over 2019-2021 and estimated to create US $10.42 million opportunity in 2027 over 2021.

Avian Pasteurellosis - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Avian Encephalomyelitis

Avian Encephalomyelitis segment was valued at US $6.79 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $15.16 million by 2027. Avian Encephalomyelitis segment represented US $1.51 million opportunity over 2019-2021 and estimated to create US $6.86 million opportunity in 2027 over 2021.

Avian Encephalomyelitis - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Avian Reovirus

Avian Reovirus segment was valued at US $4.10 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $9.15 million by 2027. Avian Reovirus segment represented US $0.91 million opportunity over 2019-2021 and estimated to create US $4.14 million opportunity in 2027 over 2021.

Avian Reovirus - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Chicken Anemia

Chicken Anemia segment was valued at US $2.63 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $5.87 million by 2027. Chicken Anemia segment represented US $0.58 million opportunity over 2019-2021 and estimated to create US $2.65 million opportunity in 2027 over 2021.

Chicken Anemia - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Services

Introduction

In 2021, Bacteriology segment has the highest revenue of US $214.36 million and is expected to grow at CAGR of 9.33% by 2027 Virology segment has highest cagr growth of 9.33%.

Poultry Diagnostics Market Y-o-Y Growth (USD million), By Services 2019 - 2027
Poultry Diagnostics Market Size, By Services, 2019-2027 (USD million)

Virology

Virology segment was valued at US $149.29 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $333.10 million by 2027. Virology segment represented US $33.17 million opportunity over 2019-2021 and estimated to create US $150.64 million opportunity in 2027 over 2021.

Virology - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Bacteriology

Bacteriology segment was valued at US $175.39 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $391.33 million by 2027. Bacteriology segment represented US $38.97 million opportunity over 2019-2021 and estimated to create US $176.98 million opportunity in 2027 over 2021.

Bacteriology - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Parasitology

Parasitology segment was valued at US $80.74 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $180.16 million by 2027. Parasitology segment represented US $17.94 million opportunity over 2019-2021 and estimated to create US $81.47 million opportunity in 2027 over 2021.

Parasitology - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Region

Introduction

In 2021, North America segment has the highest revenue of US $260.04 million and is expected to grow at CAGR of 9.33% by 2027 North America segment has highest cagr growth of 9.33%.

Poultry Diagnostics Market Y-o-Y Growth (USD million), By Region 2019 - 2027
Poultry Diagnostics Market Size, By Region, 2019-2027 (USD million)

North America

North America segment was valued at US $212.77 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $474.74 million by 2027. North America segment represented US $47.27 million opportunity over 2019-2021 and estimated to create US $214.70 million opportunity in 2027 over 2021.

North America - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Europe

Europe segment was valued at US $78.53 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $175.22 million by 2027. Europe segment represented US $17.45 million opportunity over 2019-2021 and estimated to create US $79.24 million opportunity in 2027 over 2021.

Europe - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Asia-Pacific

Asia-Pacific segment was valued at US $88.33 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $197.08 million by 2027. Asia-Pacific segment represented US $19.63 million opportunity over 2019-2021 and estimated to create US $89.13 million opportunity in 2027 over 2021.

Asia-Pacific - Historical, Forecast Market Sizes (USD million), 2019 - 2027

Rest of the World

Rest of the World segment was valued at US $25.79 million in 2019 and is projected to grow at 9.33% CAGR over the forecast period to reach US $57.55 million by 2027. Rest of the World segment represented US $5.73 million opportunity over 2019-2021 and estimated to create US $26.03 million opportunity in 2027 over 2021.

Rest of the World - Historical, Forecast Market Sizes (USD million), 2019 - 2027